On Monday, November 16, 2020, the Company, Acasti Pharma Inc., ACST stock construct a change of 0.1 percent (Gain) in a total of its share price and having its trading value $0.21, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $20.19M with the total Outstanding Shares of 96.87M.
P/S, P/E, P/B & P/C values of (NASDAQ: ACST):
Acasti Pharma Inc. institutional ownership is standing at 3.06 percent, while insider ownership is 8.64 percent. As of now, ACST has a P/S, P/E and, P/B values of 0, 0, and 1.75 respectively. Its P/Cash is valued at 0.
The stock SMA50 is now at 1.85 percent. In looking, the SMA 200 we see that the stock has seen a -57.77 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Looking into the profitability ratios of ACST stock, an investor will find its ROE, ROA, ROI standing at 0 percent, 0 percent and, 0 percent, respectively.
A beta factor is used to measure the volatility of the stock. The stock remaining at 14.11 percent volatile for the week and 7.18 percent for the month.
Gross / Operating Margins of ACST:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Acasti Pharma Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of Acasti Pharma Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 10.32 percent, resulting in a performance for the month at 2.61 percent.
Therefore, the stated figure displays a quarterly performance of -73.28 percent, bringing six-month performance to -67.44 percent and year to date performance of -91.49 percent. As of now, Acasti Pharma Inc. has a P/S, P/E and, P/B values of 0, 0, and 1.75 respectively. Its P/Cash is valued at 0.
Earnings per Share Details of Acasti Pharma Inc.:
The EPS of ACST is strolling at -0.24, measuring its EPS growth this year at 30.3 percent. As a result, the company has an EPS growth of 34 percent for the approaching year.